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Objectives: To determine the leukocyte esterase (LE) activity in vaginal lavage fluid of women with acute and
recurrent vulvovaginal candidosis (VVC and RVVC respectively), bacterial vaginosis (BV), and in pregnant and
non-pregnantwomen without evidence of the three conditions. Also to compare the result of LE tests in women
consultingatdifferentweeksinthe cycleandtrimestersof pregnancy.TheLEactivitywascorrelatedtovaginal pH,
number of inflammatory cells in stained vaginal smears, type of predominating vaginal bacteria and presence of
yeast morphotypes.
Methods: One hundred and thirteen women with a history of RVVC, i.e. with at least four attacks of the
condition during the previous year and who had consulted with an assumed new attack of the condition, were
studied. Furthermore, we studied16 women with VVC,15 women with BV, and 27 women attending for control
of cytological abnormalities, who all presented without evidence of either vaginitis or vaginosis. Finally, 73
pregnant women were investigated. The LE activity in vaginal fluid during different weeks in the cycle of 53 of
the women was measured.
Results: In the non-pregnant women, an increased LE activity was found in 96, 88, 73 and 56% of those
with RVVC, VVC and BV and in the non-VVC/BV cases, respectively. In 73% of pregnant women in the second
trimester, and 76% of those in the third, the LE test was positive. In all groups of non-pregnant women tested,
the LE activity correlated with the number of leukocytes in vaginal smears, but it did not in those who were
pregnant.There was no correlation between LE activity and week in cycle. The vaginal pH showed no correlation
to LE activity in any of the groups studied.
Conclusions: The useof commercial LEdipstickshas a limited valueinthe differentialdiagnosis ofRVVC,VVCand
BV. There is no correlation between the LE activity in vaginal secretion on one hand and vaginal pH, week in
the menstrual cycle and trimester in pregnancy on the other. Women with BV often have signs of inflammation
as evidenced by a positive LE test and inflammatory cells in genital smears.
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If the office diagnosis of vaginitis/vaginosis is
only based on history and clinical examination,
the accuracy will beunacceptablylow1–3. To diag-
nose inflammatory reactions in the lower female
genital tract, for example of vaginitis, microscopy
of vaginal fluid for detection of granulocytes has
been the standard procedure. Bacterial vaginosis
(BV) has been considered to be an –osis, that is, a
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ã 2003 The Parthenon Publishing Group 19non-inflammatory condition. Amsel’s criteria4,
which do not include the presence of inflamma-
tory cells in vaginal fluid, have generally been
employed to diagnose BV.
Leukocyte esterase (LE) tests have been
launched as one of several chemical tests on dip-
sticks employed in the diagnosis of urinary tract
infections (UTI). Contradictory results of the
diagnostic value of LE tests have been reported5,6.
A number of studies have reported on the use of
an LE dipstick test of urine to diagnose urthritis
in males7,8, while only single studies have used
such tests in the diagnosis of female genital
infections9–11.
The LE test is based on detection of an enzyme
that hydrolyses indoxyl carboxylic acid ester to
indoxyl,whichin turn reacts with a diazoniumsalt
to produce a purple colour12.
The present study was aimed to determine the
LE activity in vaginal secretion of pregnant and
non-pregnant women with and without evidence
of vaginitis and vaginosis. Samples collected at
different weeks of the menstrual cycle and at the
second and third trimesters of the gestational
period were studied. We also studied any correla-
tion between the LE test results and the number
of inflammatory cells in vaginal smears.
SUBJECTS AND METHODS
Leukocyte esterase tests and pH determinations
The LE activity was measured by a commercial
kit (Ecur4-Test, Boehringer–Mannheim, later
renamed Combur-4 and sold by Roche, Basle).
One drop (approximately 0.3 ml) of vaginal lavage
fluid was mixed with 3 ml of 0.1M TRIS HCl
buffer, pH 7.3 or with physiological saline. The
tests were performed within a couple of minutes
ofsampling.Accordingto thepackageinsert,color
changes of grades 1, 2 and 3 correspond to 10–25,
approximately 75, and approximately 500 granu-
locytes/ml, respectively.
Another 1–2 drops of the vaginal lavage were
placed on an indicator strip for pH determination
(Merck, Darmstadt, Germany). Vaginal samples
were tested for LE activity within some minutes as
well as after 6 hours’ storage2 at room temperature
in TRIS buffer and in physiological saline.
The LE activity was correlated with the pre-
dominating bacterial flora, independent of the
presence of candida morphotypes. The presence
of extremely elongated Gram-positive rods (of
lactobacilli morphotype) was also noted.
Patients with a history of recurrent vulvovaginal
candidosis
One of the cohortsstudied comprised 113 women
with a history of RVVC, i.e. patients who had
had at least four attacks of the condition during
the previous year, and who had consulted with
symptoms suggesting a new attack of RVVC. The
diagnostic criteria applied have been described in
detail elsewhere13,14. The number of these women
who had a positive LE test has already been
reported inapreviousstudy13.Inthepresentstudy,
we expanded our investigation by comparing the
LE test results with findings of candida morpho-
types, i.e. of blastoconidia and pseudohyphae, in
Gram- and methylene blue-stained vaginal smears.
Themethodsused to identify those with a positive
candida culture have been reported in detail else-
where15. In brief, vaginal introital and posterior
vaginalfornixsampleswereculturedonSabouraud
and chromogenic agar16. Speciation of isolated
candidastrainswasdonewith API50C kitsandthe
Vitek® automised identification system (bothfrom
BioMerieu, Paris). The vaginal pH was deter-
mined by pH indicator strips (Merck, Darmstadt).
The LE activity in vaginal flushing fluid samples
was determined by Combur-4® (Roche, Basle)
stick.
Patients attending for control of cytological
abnormalities
Twenty-seven women in whom a previous cyto-
logical screening had shown cell abnormalities
(but no signs of cervical cancer) were investigated.
Thepatients, all of whomwere non-pregnant,had
no signs orsymptoms of VVC or BV. The patients
were tested for LE activity, vaginal pH and for
presence of inflammatory cells and predominating
bacterial flora, i.e. either a predominance of
Gram-positive rods (of lactobacilli morphotypes)
ora mixture of bacterial morphotypes(‘BV flora’).
Furthermore, Amsel’s criteria were searched for:
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geneous vaginal content, presence of clue cells
(in methylene blue- and Gram-stained vaginal
smears), and a positive amine test obtained by
adding 15% KOH to vaginal fluid.
Patients with vulvovaginal candidosis and
bacterial vaginosis and non-pregnant healthy
women
Sixteen women with the diagnosis of VVC and
15 with BV were tested for LE activity in vaginal
secretion. BV was diagnosed if three of four of
Amsel’s criteria were fulfilled4. The VVC and
BV women were all non-pregnant.
The diagnostic methods were the same as
those applied in the cases with cytological
abnormalities. An acute attack of VVC was con-
sidered when the woman reported symptoms
such as pruritus, discharge and pain. Signs, such as
oedema and erythema of the introitus and the
vaginal mucosa with plaques, and/or an increased
vaginal discharge (often of cotton-cheese type),
were required. The presence of candida blasto-
conidia and/or hyphae in stained vaginal smears
wasalsorequiredtoconfirmthediagnosisofVVC.
Pregnant women
Seventy-threepregnantwomenwerestudied.The
sampling was made in conjunction with routine
maternal check-upsin thesecond (17–18 weeks of
gestation) and third trimester (32–34 weeks of
gestation). The diagnostic methods used for the
pregnant women were the same as those applied
to the women with cytologic abnormalities.
Statistical analyses
Data were analysed using c2 and student t-tests.
A p-value < 0.05 was considered significant.
RESULTS
Leukocyte esterase activity in cases with history
of recurrent vulvovaginal candidosis
In the 113 cases with a history of RVVC and
with symptoms suggestive of a new attack of the
condition, there was a correlation between the
LE activity and the result of the yeast cultures
from the genital tract (p < 0.05). Thus, of the 63
candida culture-positive women, all had positive
LE tests. Of the 50 culture-negative women, 45
had such an increased activity.
There was no correlation between the result of
pH determination of vaginal lavage and the result
oftheLE tests (Table 1). Thus, of 57 women with
a vaginal pH of less than 4.5, 51 (89%) had an LE
test of grades 2 and 3, while of the 43 women with
a pH of 4.5–5.4, 37 (86%) had such a result.
Eleven of the 113 women with an even higher
pH had a positive LE test (10%).
Leukocyte esterase activity in correlation to pH
in women without vaginitis/vaginosis
Table 2 lists the LE activities in the patients who
had no symptoms and/or signs of either VVC or
BV, in relation to the vaginal pH. Thus, of the 97
women studied, 76 (78%) had a vaginal secretion
pH of 4.7 or less, 45 (59%) of whom had a positive
LE test (grades 1–3). Of the 21 women with an
elevated vaginalfluidpH(above4.7),16(76%)had
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Number of women with indicated test result*
Vaginal pH
Number of cases
(n = 113)
Grades 0–1
(n = 14)
Grade 2
(n = 22)
Grade 3
(n = 77) p-value
£ 4.4
4.5–5.4
‡ 5.5–6.4
57
43
13
6
6
2
13 (12%)
7 (6%)
2
38 (34%)
30 (27%)
9 (69%)
0.904
0.903
0.927
*Grading according to package insert (Combur-4
Ò, Roche, Basle)
Table 1 Relation between vaginalpH and leukocyte esterase activity in vaginallavage fluidof women with a history of
and an assumed new attack of recurrent vulvovaginal candidiasisa positive LE test. Also in this group, there was no
correlation between vaginal pH and LE activity
(Table 2).
Leukocyte esterase activity in vulvovaginal
candidosis and bacterial vaginosis and
non-vaginitis/vaginosis cases: correlation with
occurrence of leukocytes in vaginal lavage fluid
Table 3 shows the LE test results in the VVC, BV,
and non-VVC and non-BV cases studied. In 14
(88%) of the 16 VVC cases, the LE activity was
elevated (grades 1–3). In the 15 BV cases, this
was the case in 11 (73%) patients. In the 97
non-VVC/BV cases, LE activity was elevated in
54 (56%) of the cases investigated. All the VVC
cases were symptomatic, as were six of the BV
cases. The number of granulocytes in the vaginal
smears (less than five, six to nine, or more than
ten leukocytes per high-power field, HPF) from
the 128 women, is shown in Table 3. There was
a correlation between the degree of activity of
leukocyte esterase – grades 0, 1, 2 or 3 according
to package insert – in the VVC (p = 0.021),
BV (p = 0.023) and in the non-VVC/BV cases
(p = 0.002).
Table 3 also shows the presence of leukocytes
in stained smears of vaginal secretion in relation
to LE activity in the vaginitis and vaginosis cases
and in women with no signs of these conditions.
In 12 (75%) of the 16 VVC cases, and in eight
(54%) of the 15 BV patients, there were more
than five leukocytes per HPF. In the 97 non-
VVC/BV cases, 33 (34%) had such a number of
leukocytes in vaginal lavage fluid. There was
a correlation between the number of leuko-
cytes and LE activity in the VVC (p = 0.023),
BV (p = 0.031) and non-vaginitis/vaginosis
groups (p = 0.008).
Thepositive (PPV) and negative (NPV)predic-
tive values fortheLE test (grades 2–3) to foresee an
increased number of leukocytes (six or more per
HPF) in the patients’ stained smears were 53.1 and
77.5%, respectively.
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Number of cases with indicated LE activity
Vaginal pH
Total number of women
(n = 97)
Grade 0
(n = 36)
Grade 1
(n = 17)
Grade 2
(n = 16)
Grade 3
(n = 28) p-value
£ 4.7
> 4.7
76
21
31
5
15
2
9
7
21
7
0.07
0.086
*Grading according to package insert (Combur-4
Ò, Roche, Basle)
Table 2 Correlation between grade* of leukocyte esterase (LE) activity in vaginal secretion and pH of the test
sample in women without symptoms and clinical signs of vulvovaginal candidosis and bacterial vaginosis
Number of women with given LE activity and leukocyte count
Number tested
(n = 128)
0 1 2 3
Condition A B C A B C A B C A B C
VVC
BV
Controls
16
15
97
1
3
34 3
1
1
6 8
4
1
2
1
2
1
10 2
2
8
4
3
3
12
1
1
4
6
1
11
*Grading according to package insert (Combur-4
Ò, Roche, Basle); A, < 5 leukocytes per high power field (HPF) (x1000); B, 6–9 leukocytes
per HPF; C, > 10 leukocytes per HPF
Table 3 Correlation between grade* of leukocyte esterase (LE) activity and number of leukocytes in vaginal
secretion in women with vulvovaginal candidosis (VVC) and bacterial vaginosis (BV) and in women without evidence
of these conditions (controls)Leukocyte esterase activity in relation to week
in menstrual cycle
Only three of the 64 non-pregnant women were
menstruatingatthedayofexamination.LEactivity
in relation to the start of last menstruation was
registered in 53 women. There was no correlation
between LE activity and the number of days
that had passed since the start of last menstrua-
tion (Table 4).
Twelve patients had amenorrhoea, eight of
them due to hormonal contraception. The LE
test result in this group is also shown in Table 4.
Leukocyte esterase activity in relation to
different trimesters
Of the 73 pregnant women studied, 54 (74%) had
anLEactivity ofgrades 1–3(Table 5).Ofthepreg-
nant women, 44 were in the second trimester,
while the remaining 29 women had reached the
third trimester. In the former group, 32 (73%)
and in the latter 22 (76%) women had an increased
LE activity in vaginal secretion. In contrast
with the non-pregnantwomen, there was no cor-
relation between the degree of LE activity, neither
in thesecond (p = 0.75) nor in thethird (p = 0.74)
trimester.
Leukocyte esterase activity in relation to
predominating bacterial morphotypes in
the vagina
In 56 (63%) of the 89 women with a lactobacilli-
dominated vaginal flora, independent of the
presence of candida morphotypes, LE activity
was increased. In 13 (23%) of the 56 women,
elongated, non-divided rods of lactobacilli-
morphology were detected. In the remaining
43 women with a mixed bacterial flora, increased
LE activity was found in 24 (56%). Elongated
bacteria were present in six (14%) of the 43
women, three (50%) of whom had elevated
LE activity.
Influence of storage time on leukocyte esterase
activity in samples stored in TRIS buffer versus
saline
There was no difference in LE activity between
vaginal lavage samples collected in TRIS buffer
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Number of women with indicated LE activity
Number of weeks since
last menstruation
Number tested
(n = 53)
0
(n = 33)
1
(n = 7)
2–3
(n = 13) p-value
0–1*
2
3–4**
amenorrhoea
13
12
28
11
10
8
15
5
1
1
5
3
2
3
8
3
0.332
0.335
0.090
*Ongoing or first week after last menstruation; **or longer
Table 4 Leukocyte esterase (LE) activity in relation to the number of weeks since the start of last menstruation
LE activity*
Gestational
period
Number of women tested
(n = 73)
Grade 0
(n = 19)
Grade 1
(n = 8)
Grade 2
(n = 17)
Grade 3
(n = 29) p-value
Second trimester
Third trimester
44
29
12
7
6
2
9
8
17
12
0.752
0.742
*Grading according to package insert (Combur-4
Ò, Roche, Basle)
Table 5 Leukocyte esterase (LE) activity in vaginal lavage of pregnant women in relation to gestational timeor saline. Nor was there any difference in LE
activity when analyses were made some minutes
after collection compared with the result when
the same samples had been stored for up to 6 hours
at room temperature.
DISCUSSION
The determination of LE activity with the aid of
different commercial dipsticks has been used to
screen for UTI. Some studies have favored their
use9, while others have denied their usefulness
for this purpose5,6.
Although the most common application of
LE dipsticks has been in investigations of
voided urine for UTI5,11,12,17,18 or urethritis7,8,
single reports have described their use in tests of
vaginal9 and amniotic fluids10.
LE tests are often sold in combination with
otherchemicaltests, suchastestsfornitrate,hemo-
globin and glucose, which all appear on the same
dipstick. Evaluation of the value of LE tests for
bacteriuria have often been made in the context
of concomitant tests for nitrate. However, the
specificity for detection of significant bacteriuria,
even byuseofsuchacombinationoftests, islow6.
Storageconditionsofsamples may influencethe
LE test outcome18. Thus, after 24 hours’ storage,
there is a risk for positive samples to turn negative.
In the present study, the tests in the RVVC cases
wereperformedatmostafewhoursaftersampling,
while in the other studies, within minutes.
LE tests have been used in screening programs
for genital infections of given etiologies, such
as chlamydial urethritis and gonorrhoea7,19–21.
Samples with a positive LE test have then been
subjected to a definite etiologic test. Although the
sensitivity of LE tests for detection of urethritis in
males may be high, the specificity is too low for
accurately diagnosing chlamydial and gonococcal
infections7. In a study of voided urine samples of
224 male military recruits and 443 male sexually
transmitted infection clinic patients, we used two
enzyme immunoassays, onechemilumminometric
assay and an immunofluorescence test to detect
Chamydia trachomatis. The PPV of LE tests for
detection of a genital chlamydial infection was
only 44.6%21.
LE dipstick tests of urine from men with symp-
tomatic trichomoniasis have a higher sensitivity
(80%) than specificity (40%)22. In the asymptom-
atic cases of trichomoniasis, the corresponding
values were 60 and 68%, respectively. A negative
LE test seems to exclude trichomoniasis. In our
clinical setting, trichomoniasis is today a rare
condition, which was never diagnosed in any of
the cases presented in our study.
LE tests have been used to detect asymptomatic
bacteriuria in obstetric patients23,24, and also
‘vaginitis of unspecific aetiology’ in such patients.
Thus, Abbasi and co-workers9 found LE dipstick
tests to have a 100% sensitivity and 90% specifi-
city for detection of such latter cases. They also
reported a sensitivity and specificity of 100% for
detection of UTI in their patients. In the current
study, none of our pregnant women had a recent
history of  UTI.
BV is generally believed to be an ‘–osis’ and
not an ‘–itis’. In the present study, we used
Amsel’s criteria4 to diagnose BV. These criteria
do not include any tests for the absence of
leukorrhea.However,ofour15BVpatients,seven
(47%) had an increased number of leukocytes in
vaginal secretion. Furthermore, more than two-
thirds (11/15) of the BV cases (defined by Amsel’s
criteria) had a positive LE test. BV has been con-
sidered a risk factor for premature birth, although
this is contradicted by several recent prophylactic
antibiotic studies25. There appears to be a need to
recognize the subgroup of pregnant women with
BV that seems to be at particular risk to deliver
before term. The possibility to use LE tests of
vaginal fluid for identifying women at risk should
be explored.
The pH of vaginal secretions did not correlate
with LE activity in the VVC, BV and non-BV,
non-VVC cases. However, some of the women
who were diagnosed with BV (i.e. presented with
three of the four Amsel’s criteria) had a normal
vaginal pH, just as some of the VVC cases had
an increased pH. These observations contradict
the ‘text book knowledge’ on both vaginosis
and vaginitis.
The cycle day might have influenced the LE
test result. We found more positive LE tests in
the luteal than in the follicular phase, but the
difference was not significant. Only three of the
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that performance of the LE test is not interfered
withbythepresenceofbloodinthetestsample).
None of the women were using imipenem,
meropenem or clavulanic acid, which all can
interfere with the LE test and produce false posi-
tive results. Neither had they been prescribed
cephalexin orgentamycin, whichcan diminish the
color on the test stick if taken in high doses. In
addition, excessive excretion of glucose in urine
that contaminates vaginal secretion can have such
an influence. In all the pregnant women studied,
careful evaluation of the presence of metabolic
syndrome had been made as part of the routine
maternal check-upat theclinic. Twowomenwith
gestationaldiabeteswere includedinthestudy,but
they were both metabolically well-controlled.
The PPV of LE dipstick tests for detection of
polymorphonuclear leukocytes in urine samples is
low26. This was also true in the present study
of vaginal secretions of women with vaginitis.
In RVVC, the vaginal content has often been
described as being dominated by monocytes. Our
study also showed leukocytes to be present in high
numbers in many of the VVC and RVVC cases.
Our study points to the value of examining
vaginal smears in the work-up of cases suspected
suffering from RVVC13. If the diagnosis of this
condition is based only on history and clinical
examination, approximately half of all such
cases will prove negative for Candida species2.
Differentiation between candida-positive and
candida-negative cases among women presenting
with symptoms and signs generally associated with
RVVC is not possible with any high degree of
accuracy14. The use of one or more doctors’ office
tests, such as culturesand/ormicroscopy ofstained
introital and vaginal smears, is essential in the
work-up of cases consulting with genital symp-
toms. However, our study did not show any
benefit from LE determinations by dipstick tests
of vaginal secretion in this conjunction.
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